Long term aHUS effects
Long term aHUS disease, diagnosis and treatment legacies on both physical and mental health have featured in two aHUS Patient Research…
Long term aHUS disease, diagnosis and treatment legacies on both physical and mental health have featured in two aHUS Patient Research…
Eculizumab was approved by the US Food and Drugs Administration for PNH for 15 years ago on 16 March. This September…
A very important topic for many aHUS patients around the world with an unmet need. Patients have included the topic in…
Let us kick off the responses to the RDD2022 Video with a couple of questions about the characteristics of aHUS patients.…
When Jeff, the producer of these awareness day videos, suggested that "questions" should be the theme of this years' RDD Video…
It was March 2020 and COVID appears on www.ahusallianceaction.org for first time with a question: Can the coronavirus trigger an infection…
The third article in the series about the aHUS Diagnosis Process is published today. Rare Disease Day 2022 The article covers…
aHUS alliance Global Action has previously brought up the concept of "Long aHUS " in its articles during the COVID pandemic.…
Iptacopan is a complement inhibitor that it is taken orally, twice daily. It works by inhibiting Complement Factor B (CFB ).…